Alterations of the Expression of TET2 and DNA 5-hmC Predict Poor Prognosis in Myelodysplastic Neoplasms

Researchers studied the expression and the variants of TET2 in Indian myelodysplastic Neoplasms (MDS) and AML-myelodysplasia-related patients and their effects on 5-hydroxymethyl cytosine (5-hmC) and on the prognosis of MDS patients.